General Writings on Brain, Mind and Language
A comprehensive archive on neurology, trauma, behaviour, and the human experience.
Explore the medical cannabis collection — 26 articles on evidence, clinical uses, safety and unusual case reports.
Explore psilocybin and psychedelic therapy — thirty articles organised into clinical applications, addiction, and safety and treatment practice.
Trauma & Interpersonal Harm
Essays that look closely at the dynamics of harm and how recovery is often misunderstood.
- Victims of Street CrimeReflections on what happens to people after street crime.
- Adult Sexual Trauma and RapePsychological and relational consequences.
- On Stalking and Being StalkedExamination of obsession and the lived experience.
- Stalking and the Problem of Other People A personal account of stalking, bystander reactions, unwanted interventions and keeping records.
- Stalking, Social Networks and Smear Campaigns How shared friendships and professional contacts become entangled with allegations and unwanted contact.
- Stalking, Manipulation and the Two Kinds of Lie Changing demands, promises to stop, distorted truths and entirely fabricated accusations.
- When Stalking Begins: Before the Target Recognises It The difference between the start of intrusive behaviour and the moment it becomes visible to the target.
- What Does a Stalker Want? Responses, Boundaries and Their Limits Clever replies, the imagined relationship, public responses and the limits of no contact.
- Covert Emotional Enmeshment and Parentification Exploring hidden relational roles where emotional needs overshadow individuality.
- The Effort to Drive the Other Person CrazyOn gaslighting and coercion.
- The Weaponization of Veracity How truth, credibility, and plausibility are manipulated as tools of interpersonal control.
- The Enforced Narrative How dominant stories constrain discourse and marginalise alternative perspectives of selfhood.
- Tone Policing How dismissive evaluative judgments shut down genuine communication.
- Weaponised Forgiveness How the rhetoric of forgiveness is used to avoid accountability and perpetuate harm.
- The Extinction Burst Understanding the behavioural spike that precedes change and its implications.
- Flippant Reframing How a real problem is trivialised, redirected, and reframed through dismissive presupposition.
- Sibling Triangulation How family dynamics recruit siblings into alliances, conflict, and psychological positioning.
- Somatic Dysregulation When the body’s regulatory systems become chronically unsettled, shaping emotion, perception, and behaviour.
- It Is Not My Fault: The Blame ListA look at externalizing responsibility.

Sexual Health, Body & Identity
Articles on how our bodies and identities become medicalised or moralised.
- On Being FatExploration of weight, shame, and identity.
- Premature EjaculationPsychological meanings of the experience.
- Definitions and Treatment StrategiesUnpacking definitions and reviews.
- A Clinical Note on Penile FracturesRarely-discussed injury implications.
- Impotence and Its Psychological ImplicationsIdentity, shame, and stories.

Alcohol, Addiction & Behaviour
Examining alcohol use and how labels shape identity and social attitudes.
- Alcohol DependencyThe cost of mislabelling and identity.
- Alcohol, Alcoholism and Alcohol DependencyTeasing apart different concepts.
- Alcohol: The Blameless DrugCultural normalization and blame.
- Alcohol, Cultural Permission, and the Myth of the Blameless Drug An examination of alcohol as a socially protected intoxicant, its cultural narratives, and its role in dependency.

Mood, Depression & Communication
How interaction and inner imagery can relieve or worsen distress.
- Anger: Prevention and ManagementAnger as a signal and habit.
- Tangential ResponsesConversation patterns and depression.
- Visual Imagery and DepressionThe role of inner mental imagery.
- It’s Good to TalkWhat talking actually does in therapy.
- Continuity, Discontinuity, and the Clinical Structure of Attachment Loss Understanding the significant psychological impact of losing foundational attachments.
- Loss, Attachment Substitution, and the Ritual Management of Absence Exploring how the human mind manages grief and absence through psychological substitution and ritual.
- The Meta-Model Misapplied – Part 1: Reflexive Questioning Why stock questions can redirect a client’s meaning, and how to listen for structure. Includes video.
- The Meta-Model Misapplied – Part 2: Structured Intervention How questions, perspective and timing connect with an intervention’s purpose. Includes video.

Complex Presentations & Controversial Diagnoses
Where psychiatry, belief, and suggestion collide.
- Munchausen’s SyndromeChallenges of diagnosing factitious disorder.
- False Memory SyndromeMoral panics and suggestibility.

Medical Cannabis: Evidence, Uses and Case Reports
A collection of 26 articles on cannabinoid medicines, clinical uses and unusual case reports, with evidence summaries, credited public-domain images and links to original research and clinical guidance.
Start here: How to read the evidence, then choose a clinical topic below. Case reports generate questions; they do not establish that a treatment works for everyone.
Understand the evidence
- How to read medical cannabis researchCase reports, registries, trials and the outcomes that matter.
- CBD in medicineBenefits, limitations, prescription products and adverse effects.
- THC, CBD, terpenes and strain namesWhat a product description can and cannot tell you.
- UK prescriptions and safer useProducts, prescribing, driving and follow-up.
- Medicine interactions and monitoringSedation, drug handling and coordinated medication review.
Clinical uses and their limits
- Chronic painAverage benefits, adverse effects and the latest AHRQ review.
- MS spasticity and SativexThe defined role of THC:CBD spray and the initial response assessment.
- CBD for epilepsyPurified prescription CBD, specific syndromes and seizure outcomes.
- Chemotherapy-related nausea and vomitingWhere nabilone and THC:CBD fit alongside conventional antiemetics.
- Cancer and palliative careSymptom relief, treatment burden and the limits of anti-cancer claims.
- Irritable bowel syndromeGut symptoms, the endocannabinoid system and the limits of current studies.
- Crohn’s disease and ulcerative colitisWhy symptom relief is different from controlling inflammation.
- InsomniaSleep outcomes, next-day effects and the evidence for cannabinoids.
- Anxiety and PTSDDifferent effects of THC and CBD, with careful attention to uncertainty.
- Palliative care and multiple sclerosisComfort, capability and the place of cannabis within wider MS care.
Further evidence and unresolved questions
Focused reviews of mixed results, negative findings and the questions that remain open.
- Fibromyalgia and the larger CBD trialWhy a placebo-favouring result changes the interpretation of earlier encouraging reports.
- Can medical cannabis reduce opioid use?Fewer tablets, total treatment burden and the limits of observational evidence.
- CBD, schizophrenia and psychosisConflicting reviews, small effects and the claim that CBD protects against THC.
- CBD and autismMixed primary outcomes, secondary signals and goals that matter to autistic people.
- Medical cannabis in older adultsBalance, alertness, appetite, dementia symptoms and who was actually studied.
- CBD, THC and next-day impairmentNegative performance tests, subjective sedation and the limits of laboratory reassurance.
Case reports: unusual benefits and harms
- Severe itchingWhat an unusual treatment response can suggest, and what it cannot prove.
- Speech-blocking tics in Tourette syndromeIndividual reports, speech outcomes and the wider tic evidence.
- CBD and REM sleep behaviour disorderAn encouraging case series followed by a controlled trial.
- Prescription CBD and warfarinCase reports that illustrate a clinically important monitoring concern.
- Paradoxical vomiting with prescription CBDA rare adverse-effect report and the limits of drawing conclusions from one case.
Collection expanded 11 October 2026. These articles provide educational information and do not replace individual clinical assessment.
Psilocybin and Psychedelic Therapy
Thirty clinical articles covering potential benefits, negative findings, safety and unresolved questions across psilocybin and related treatments.
Clinical applications
Psilocybin for Depression: Benefits, Limitations and Lasting Recovery
Psilocybin for depression: antidepressant benefits, negative findings, comparison with escitalopram, relapse, safety and the meaning of recovery.
Ketamine and Esketamine for Depression: Benefits, Maintenance Treatment and Clinical Limits
Ketamine and esketamine for depression: comparative benefits, negative findings, relapse prevention, psychotherapy, monitoring and UK and US access.
DMT for Depression: Rapid Effects, Clinical Evidence and the Limits of a Short Experience
DMT for depression: controlled and open-label findings, treatment duration, medication review and the distinction from 5-MeO-DMT and ayahuasca.
Psilocybin for Bipolar Depression: Antidepressant Effects, Hypomania and Mood Stability
Psilocybin for bipolar II depression: early antidepressant findings, hypomania, sleep disruption, lithium interactions and long-term mood stability.
Psilocybin in Cancer and Palliative Care: Distress, Meaning and Choice
Psilocybin for cancer-related anxiety, depression and existential distress, with attention to durability, palliative care, consent and treatment burden.
LSD for Anxiety Disorders: Symptom Relief, Treatment Burden and Lasting Recovery
LSD for anxiety: published trials, 2026 sponsor-reported phase 3 findings, psychological support, long sessions, adverse effects and lasting recovery.
Psilocybin for Obsessive–Compulsive Disorder: Symptoms, Treatment and Clinical Evidence
Psilocybin for OCD: compulsions, recent clinical trials, exposure and response prevention, medication, safety and lasting functional improvement.
Psilocybin for Body Dysmorphic Disorder: Appearance Preoccupation, Symptoms and Recovery
Psilocybin for body dysmorphic disorder: preliminary clinical findings, appearance preoccupation, brain imaging, psychological care and recovery.
Psilocybin for Anorexia Nervosa: Psychological Change, Nutrition and Medical Safety
Psilocybin for anorexia nervosa: psychological symptoms, nutritional recovery, pilot findings, medical vulnerability and continuing specialist care.
Psilocybin for Migraine and Cluster Headache: Prevention, Pain and Clinical Evidence
Psilocybin for migraine and cluster headache: attack prevention, controlled trial results, negative findings, safety and established headache care.
Psilocybin for Fibromyalgia and Chronic Pain: Symptoms, Function and Treatment Limits
Psilocybin for fibromyalgia and chronic pain: pain intensity, daily function, early clinical findings, phantom limb pain and continuing treatment.
Psilocybin for PTSD: Trauma Symptoms, Psychological Support and Clinical Evidence
Psilocybin for PTSD: early clinical findings, trauma symptoms, psychological support, memory, safety and the separate evidence for MDMA therapy.
MDMA-Assisted Therapy for PTSD: Clinical Benefits, Safety and Continuing Care
MDMA-assisted therapy for PTSD: controlled outcomes, expectation, cardiovascular safety, consent, professional boundaries and continuing trauma care.
Psilocybin in Parkinson’s Disease: Depression, Anxiety and the Limits of Motor Improvement
Psilocybin in Parkinson’s disease: mood symptoms, exploratory motor and cognitive findings, medication safety and the absence of proven disease modification.
Psilocybin for Healthcare Worker Depression and Burnout: Recovery and Working Conditions
Psilocybin for healthcare worker depression and burnout: controlled findings, uncertain burnout benefits, confidentiality and the need to address working conditions.
Psilocybin in HIV Care: Demoralisation, Shame and Psychological Recovery
Psilocybin in HIV care: demoralisation, HIV-related shame, trauma-related adverse effects, group therapy and the continuing importance of antiretroviral treatment.
Addiction
Psilocybin for Alcohol Use Disorder: Drinking, Relapse and Recovery
Psilocybin for alcohol use disorder: heavy drinking, negative relapse-prevention findings, psychotherapy, withdrawal and sustained recovery.
Psilocybin for Smoking Cessation: Nicotine Dependence, Abstinence and Relapse
Psilocybin for smoking cessation: nicotine dependence, randomised trial findings, sustained abstinence, relapse and established treatment options.
Psilocybin for Cocaine and Methamphetamine Use Disorders: Abstinence, Craving and Recovery
Psilocybin for cocaine and methamphetamine use disorders: a randomised cocaine trial, early methamphetamine findings, craving, safety and sustained recovery.
Psilocybin for Opioid Use Disorder: Early Evidence and the Priority of Established Care
Psilocybin for opioid use disorder: the buprenorphine pilot, mixed population findings, reward learning, overdose prevention and established treatment.
Safety and treatment practice
Psilocybin-Assisted Therapy: Clinical Uses, Mechanisms and Patient Care
A clinical account of psilocybin-assisted therapy: mechanisms, medical applications, psychological support, patient selection and continuing care.
Expectancy and Evidence in Psychedelic Therapy: Placebo Effects, Blinding and Reliable Treatment Claims
How expectancy, blinding, comparison treatments and follow-up affect psychedelic treatment claims, including negative results and unresolved questions.
Consent and Safeguarding in Psychedelic Therapy: Touch, Boundaries and Professional Accountability
Consent and safeguarding in psychedelic therapy: therapeutic touch, changing wishes, suggestibility, professional boundaries, privacy and independent accountability.
How Psilocybin Affects the Brain: Receptors, Networks and Therapeutic Change
How psilocybin affects serotonin receptors, brain networks and plasticity, and why biological changes do not by themselves establish clinical recovery.
Psilocybin and Psychedelic Therapy: Adverse Effects and Patient Safety
A clinical assessment of psychedelic safety: acute adverse effects, persistent symptoms, interactions, psychiatric vulnerability and professional care.
Difficult and Prolonged Reactions to Psychedelics: Anxiety, Dissociation and Persistent Perceptual Symptoms
Difficult and prolonged psychedelic reactions: anxiety, dissociation, HPPD, the limits of risk estimates, professional assessment and recovery.
Psilocybin and Prescribed Medicines: Antidepressants, Interactions and Withdrawal
Psilocybin and prescribed medicines: SSRIs, withdrawal, lithium, serotonin toxicity and the distinction between altered drug effects and clinical benefit.
Psychological Support in Psilocybin Therapy: Preparation, Consent and Integration
Preparation and integration in psilocybin therapy: therapeutic alliance, consent, professional boundaries, follow-up and unresolved questions about effectiveness.
Psilocybin Therapy Over Time: Durability, Relapse and Repeat Treatment
Long-term psilocybin outcomes: response, remission, one- and five-year follow-up, relapse, continuing care and the unresolved role of repeat treatment.
Psilocybin Microdosing: Mood, Cognition and the Limits of Clinical Evidence
Psilocybin microdosing: controlled findings on mood and cognition, creativity, expectation, clinical applications and unresolved long-term safety.
Body, Brain & Unusual Treatments
From seizures to microbiota, exploring the stranger corners of medicine.
- Fecal Microbiota TransplantA first-hand account of FMT treatment.
- Epilepsy, Light and Sound MachinesSeizure risks and relaxation devices.
- Panchagavya & AyurvedaTraditional remedies through a modern lens.

Consciousness & Radical Ideas
Essays challenging conventional views of mind and experience.
- Near-Death Experience (NDE)What they tell us about mind and belief.
- Past Life RegressionA critical exploration of regression, memory, belief, and therapeutic meaning.
- Photographic MemoryA critical look at the research.
- Wilhelm ReichLife and work of the controversial figure.
- The Politics of ExperienceHow culture shapes "normal" experience.
- Agents of the New CountercultureEmerging movements.
- Life at All CostsOn the ethics and psychology of preserving life, intervention, death, and medical authority.
- Archetypes, Persona and the Stories We Live By Religious stories, tarot symbolism, persona and the difference between discovery and an improved performance of self.
- Life at All Costs? Resuscitation, End-of-Life Care and the Question of Suffering Nursing recollections, patient wishes and the ethical questions surrounding prolonged treatment. Includes video.
